Premium
Drug Eluting Stents: Arsenic Trioxide–Coated Stent Is an Endothelium‐Friendly Drug Eluting Stent (Adv. Healthcare Mater. 15/2018)
Author(s) -
Zhao Yinping,
Du Ruolin,
Zhou Tian,
Yang Dongchuan,
Huang Yuhua,
Wang Yi,
Huang Junli,
Ma Xiaoyi,
He Fugui,
Qiu Juhui,
Wang Guixue
Publication year - 2018
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201870058
Subject(s) - restenosis , drug eluting stent , stent , arsenic trioxide , medicine , neointimal hyperplasia , intimal hyperplasia , materials science , surgery , arsenic , metallurgy , smooth muscle
Traditional drug‐eluting stents often delay endothelialization whilst inhibiting intimal hyperplasia. In article 1800207 by Juhui Qiu, Guixue Wang, and co‐workers, an arsenic trioxide‐eluting stent effectively facilitates rapid re‐endothelialization whilst preventing in‐stent restenosis. Cover image designed and produced by Jin Yang.